Oncotelic Therapeutics, Inc. Convertible Debt
Oncotelic Therapeutics, Inc. (OTLC) had Convertible Debt of $1.00 million as of 2022-03-31, per its 10-Q filed 2022-05-23.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:ConvertibleDebt · last filed 2022-05-23
- 2022-03-31: Convertible Debt $1.00M.
- 2021-12-31: Convertible Debt $1.00M.
- 2021-09-30: Convertible Debt $1.00M.
- 2021-06-30: Convertible Debt $1.00M.
| Period end | Convertible Debt |
|---|---|
| 2022-03-31 | $1.00M 10-Q · filed 2022-05-23 |
| 2021-12-31 | $1.00M 10-K · filed 2022-04-15 |
| 2021-09-30 | $1.00M 10-Q · filed 2021-11-22 |
| 2021-06-30 | $1.00M 10-Q · filed 2021-08-20 |
| 2021-03-31 | $1.00M 10-Q · filed 2021-05-24 |
| 2020-12-31 | $1.00M 10-K · filed 2021-04-15 |
| 2020-09-30 | $1.00M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $1.00M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $1.00M 10-Q · filed 2020-06-29 |
| 2019-12-31 | $1.00M 10-K · filed 2020-05-14 |
| 2019-09-30 | $1.20M 10-Q · filed 2019-11-19 |
| 2019-06-30 | $800.00K 10-Q · filed 2019-08-19 |